[HTML][HTML] Therapeutic potential of CAR T cell in malignancies: A scoping review

AZ Mehrabadi, R Ranjbar, M Farzanehpour… - Biomedicine & …, 2022 - Elsevier
Although tremendous advancements in cancer therapy over the last several years, cancer
still is a complex illness to cure. Traditional cancer treatments, including chemotherapy …

[HTML][HTML] Advances and challenges in the treatment of lung cancer

Y Li, B Yan, S He - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Lung cancer accounts for a relatively high proportion of malignant tumors. As the most
prevalent type of lung cancer, non-small cell lung cancer (NSCLC) is characterized by high …

[HTML][HTML] Unraveling therapeutic opportunities and the diagnostic potential of microRNAs for human lung cancer

O Sweef, E Zaabout, A Bakheet, M Halawa, I Gad… - Pharmaceutics, 2023 - mdpi.com
Lung cancer is a major public health problem and a leading cause of cancer-related deaths
worldwide. Despite advances in treatment options, the five-year survival rate for lung cancer …

[HTML][HTML] Advancements and challenges in oncolytic virus therapy for gastrointestinal tumors

Y Li, HY Duan, J Ye - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Background Tumors of the gastrointestinal tract impose a substantial healthcare burden due
to their prevalence and challenging prognosis. Methods We conducted a review of peer …

Artificial viruses: A nanotechnology based approach

S Shaik, R Kumar, M Chaudhary, C Kaur… - DARU Journal of …, 2024 - Springer
Objectives The main objective of this work was to review and summarise the detailed
literature available on viral nanoparticle and the strategies utilised for their manufacture …

[HTML][HTML] MicroRNAs and Stem-like Properties: The complex regulation underlying stemness maintenance and cancer development

G Divisato, S Piscitelli, M Elia, E Cascone, S Parisi - Biomolecules, 2021 - mdpi.com
Embryonic stem cells (ESCs) have the extraordinary properties to indefinitely proliferate and
self-renew in culture to produce different cell progeny through differentiation. This latter …

Oncolytic viruses in lung cancer treatment: A review article

H Sakhi, M Arabi, A Ghaemi, A Movafagh… - …, 2024 - Taylor & Francis
Lung cancer has a high morbidity rate worldwide due to its resistance to therapy. So new
treatment options are needed to improve the outcomes of lung cancer treatment. This study …

[HTML][HTML] Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future

A Yarahmadi, M Zare, M Aghayari, H Afkhami… - Cell Communication and …, 2024 - Springer
Cancer, ranked as the second leading cause of mortality worldwide, leads to the death of
approximately seven million people annually, establishing itself as one of the most …

[HTML][HTML] Remodeling the tumor immune microenvironment with oncolytic viruses expressing miRNAs

G St-Cyr, D Penarroya, L Daniel, H Giguère… - Frontiers in …, 2023 - frontiersin.org
MiRNAs (miRNA, miR) play important functions in the tumor microenvironment (TME) by
silencing gene expression through RNA interference. They are involved in regulating both …

[HTML][HTML] Current immune therapeutic strategies in advanced or metastatic non-small cell lung cancer

J Xu, C Liu, X Wu, J Ma - Chinese Medical Journal, 2023 - journals.lww.com
Immune escape mechanisms in non-small cell lung cancer (NSCLC) can disrupt every step
of the anti-cancer immune response. In recent years, an increased understanding of the …